For reprint rights or to purchase a copy of your Daily Journal photo, email Jeremy_Ellis@dailyjournal.com for prices or call 213-229-5424.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

General News

May 25, 2017

Ignyta closes $88.4M offering with help from Latham & Watkins, Cooley

The Cooley team was led from San Diego by partners Charles S. Kim, David G. Peinsipp and Jason Kent, and included special counsel James C. Pennington and associate Denny Won.

Latham & Watkins LLP advised Ignyta Inc., a San Diego-based biotechnology company focused on medicines designed to treat cancer, in its roughly $88.4 million public offering of stock. Ignyta announced the deal closing on May 9.

Ignyta offered 14.375 million shares of its common stock at $6.15 each. The shares offered include 1.875 million shares issued as the underwriting syndicate fully exercised its over allotment option.

Cooley LLP advised the underwriting syndicate, led by J....

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.